Skip to main content
Fig. 2 | AIDS Research and Therapy

Fig. 2

From: Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil

Fig. 2

eGFR changes during the study period (48 weeks). Changes in eGFR over the follow-up period in relation to baseline in all analyzed patients are shown in the central line and in the subgroups of patients with eGFR ≤ 90 mL/min/1.73 m2 (n = 162) and eGFR > 90 mL/min/1.73 m2 (n = 230)

Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us